Engflag

Norethisterone

Quick links to important sections

Norethisterone

Norethisterone_IT

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norethisterone

What is Norethisterone?

Norethisterone is a synthetic form of progesterone, a naturally occurring female sex hormone. It belongs to a group of medications known as progestogens. Because it mimics the effects of natural progesterone in the body, it is used to manage various conditions related to the menstrual cycle and hormonal balance.

Mechanism of Action

In a typical menstrual cycle, levels of progesterone rise and fall to regulate the lining of the womb. Norethisterone works by acting on the progesterone receptors in the uterus. By maintaining high levels of progestogen, it can prevent the lining of the uterus from shedding, which is the process that results in a menstrual period.

Common Uses

Norethisterone is frequently utilized for the following purposes:

  • Delaying Menstruation: It can be used to temporarily postpone a period for personal or medical reasons.
  • Menstrual Disorders: It is used to manage heavy, painful, or irregular periods.
  • Endometriosis: It may be used to treat symptoms of endometriosis, a condition where tissue similar to the lining of the womb grows in other areas.
  • Hormone Replacement Therapy (HRT): It is sometimes included as the progestogen component in combined HRT treatments for menopausal symptoms.

Formulations

The medication is most commonly available in tablet form. Depending on the specific condition being treated, it may be prescribed for short-term use—such as for period delay—or as part of a longer-term cyclical or continuous treatment plan.

Regulatory References

  1. Norethindrone drug information

What side effects are possible with Norethisterone?

Possible side effects and safety information

The official safety profile for Norethisterone is structured by regulatory bodies to distinguish between common, anticipated effects and rare, serious adverse reactions.

Adverse Reaction Classification

Side effects are classified by their frequency, based on clinical data. Very Common or Common adverse reactions frequently involve the Reproductive System (e.g., irregular bleeding, spotting, changes in menstrual flow) and the Nervous System (e.g., headache). Other common effects documented in the official labeling include changes in body weight, mood disturbances, and breast tenderness. Adverse reactions are grouped across System-Organ Classes including Vascular, Psychiatric, Gastrointestinal, and Skin disorders.

Serious Adverse Reactions

The regulatory profile explicitly documents rare but serious adverse reactions, which include the potential for Thromboembolic Events, such as Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction (MI), and Stroke. Although rare, the development of Hepatic Neoplasia (e.g., liver adenomas or carcinomas) is also a documented safety concern. New onset of unusually severe headaches or sudden visual disturbances are noted as signs that warrant assessment.

Population and Duration Safety Constraints

Safety constraints and restrictions are defined for specific patient populations. The medication is officially contraindicated in individuals with known or suspected hormone-sensitive malignancy (e.g., breast cancer), a history of thromboembolic disorders, or severe hepatic impairment. The regulatory labeling specifies that the risk of Venous Thromboembolism (VTE) is highest during the initial phase of treatment, particularly within the first year of use. Individuals with conditions sensitive to fluid retention, such as epilepsy or migraine, are noted as requiring careful observation.

Overdose and Emergency Response

Official Regulatory Information: Overdose and When to Seek Help

The official regulatory profile for Norethisterone states that the compound is generally associated with very low acute toxicity. Reports of acute overdosage, as documented in regulatory labeling, indicate that the expected manifestations are typically non-life-threatening.

Overdose Presentation Regulatory Status
Documented Manifestations Nausea, vomiting, breast enlargement (mastodynia), and vaginal bleeding (may present later as withdrawal bleeding).
Severity Classification Low acute toxicity; no specific severe or life-threatening outcomes are listed as direct consequences of acute overdosage.

Required Emergency Actions and Management

In the event of a suspected overdosage, immediate medical attention is required. This action is necessary to ensure proper assessment and supportive care.

  • Antidote Status: Regulatory documents state that no specific antidote is known for Norethisterone.
  • Management: Treatment is defined as symptomatic and supportive. For a large overdose, gastric lavage may be considered, particularly if the patient is seen within four hours of ingestion.

Specific Considerations

Regulatory information identifies a risk of virilisation of female fetuses if the compound is administered at high doses during the hormone-sensitive stage of development, specifically from day 45 of pregnancy onwards.

Therapeutic Uses of Norethisterone

What Norethisterone Treats: Main Uses and Benefits

Norethisterone, a synthetic progestin, is commonly used to help with symptoms related to systemic imbalance and supports general well-being during symptomatic phases. Its use is applied across domains where additional symptomatic support is needed in conditions where functional stability becomes affected due to hormonal issues.

The therapeutic uses focus on situations involving acute or disruptive symptom patterns. It is indicated for the treatment of secondary amenorrhea (absence of periods), endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic disease. This medication is considered relevant for easing symptoms related to physical discomfort and may assist with managing symptoms that interfere with daily functioning.

The therapeutic domain is used in settings marked by temporary physiological imbalance. For example, during flare-ups associated with endometriosis, the medication may assist with easing the overall symptom load and contributes to improved comfort during periods of heightened symptoms. The use is applied in clinical settings that involve acute or unstable symptom patterns.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Norethisterone eligibility is strictly defined by regulatory authorities based on a patient’s health status and physiological condition.

Absolute Contraindications

Use of Norethisterone is formally prohibited in several populations. It is contraindicated for individuals with a history of or active thromboembolic disorders (such as deep vein thrombosis, pulmonary embolism, stroke, or heart attack). It must not be used in cases of known or suspected pregnancy due to the potential for fetal harm, specifically mild virilization of a female fetus. Absolute contraindications also include known, suspected, or history of breast cancer, as well as markedly impaired liver function or active liver disease. Use is also prohibited with undiagnosed abnormal vaginal bleeding.

Conditional Use and Population Restrictions

The medicine is generally not recommended in postmenopausal or elderly women, and for pediatric use, it should not be started before the onset of menstruation. Caution is required for patients with certain comorbidities, including epilepsy, migraine, asthma, and cardiac or renal dysfunction, as the drug may cause fluid retention. Use must be discontinued four weeks before and for two weeks following major surgery or prolonged immobilization due to the risk of thromboembolism. During lactation, use is generally compatible with breastfeeding for low-dose contraception, but caution is recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation details specific interaction patterns for Norethisterone (Norethindrone) based primarily on its metabolic pathway and the potential for severe outcomes with certain drug classes.

Formally Contraindicated Combinations

Co-administration with combination direct-acting antiviral (DAA) regimens used to treat Hepatitis C, such as those containing ombitasvir, paritaprevir, or dasabuvir, is formally restricted. This prohibition is stated in the labeling due to the officially documented risk of elevated liver enzymes (ALT).

Pharmacokinetic Interactions

The interaction profile includes substances that alter systemic exposure by affecting metabolic enzymes. Medications classified as CYP enzyme inducers, including certain anticonvulsants (e.g., Phenytoin, Carbamazepine) and anti-infectives (Rifampicin), may increase the metabolism of Norethisterone, leading to reduced progestogen levels.

Conversely, strong or moderate CYP3A4 inhibitors (e.g., certain antifungal medicines) may increase the systemic concentrations of Norethisterone.

Other Documented Interactions and Restrictions

  • Exposure Modification: Co-administration may result in increased plasma levels of Cyclosporine or necessitate adjustments in the dosing of anticoagulants (e.g., Warfarin).
  • Food and Herbal Products: The herbal product St. John's wort may induce metabolism and reduce hormone levels. Grapefruit juice may increase blood levels of the medicine.
  • Timing Restriction: A mandatory timing restriction is enforced around procedures, requiring discontinuation of the medicine 4 weeks before and until 2 weeks after major surgery or prolonged immobilization.

Mechanism of Action

How Norethisterone Works — Mechanism of Action

Central Regulation of the Reproductive Hormone Axis

Norethisterone acts as an agonist on the Progesterone Receptor (PR) in the brain and pituitary gland. This central action suppresses the release of Luteinizing Hormone (LH) and other signals from the Hypothalamic-Pituitary-Ovarian (HPO) axis, leading directly to the physiological consequence of suppressed ovulation .

Uterine Lining and Cervical Barrier Transformation

The drug exerts a direct, peripheral effect on the reproductive tract. In the uterus, Norethisterone causes the endometrium (lining) to undergo premature secretory transformation and atrophy, resulting in tissue that is lacking synchronized differentiation. Simultaneously, it increases the viscosity of cervical mucus, creating a dense physical barrier that fundamentally constrains movement within the upper reproductive tract.

Secondary and Metabolite Mechanisms

Norethisterone possesses a weak agonist action at the Androgen Receptor (AR), and its activity is partially constrained by metabolic conversion via the 5alpha-reductase enzyme to a less potent metabolite. This overall profile enables counter-regulation in combination products, where Norethisterone's mechanism must oppose the proliferative effect of estrogen to regulate uterine tissue morphology.

Dosage and Administration Information

How to Use Norethisterone: Official Administration Guidelines

Norethisterone (also known as Norethindrone) is administered primarily as an oral tablet for all established indications. The specific regimen, including the dose and duration, is determined by the condition being addressed.

Administration Scope

Parameter Official Instruction Parameter
Route of administration Oral
Dosing schedule Varies widely by use: Ranges from 0.35 mg daily for continuous contraception to 2.5 mg to 10 mg daily for short courses. Higher doses, such as up to 15 mg daily via titration, are documented for long-term conditions like endometriosis.
Timing in relation to meals May be taken with or without food.
Age-group administration rules Use is not recommended before menarche (the first menstruation).
Missed-dose rules For contraceptive use (0.35 mg), if a dose is missed by more than 3 hours, the guidance requires taking the missed tablet immediately and using a backup contraceptive method for the subsequent 48 hours.
Special procedural conditions Contraceptive tablets must be taken at the same time every day to ensure consistent use.

Use Protocol and Frequency

Administration frequency is typically once daily, although higher doses may involve divided doses. The treatment course is structured either as a short-term course (e.g., 5 to 10 days) for acute issues like abnormal bleeding, or as a long-term cycle (e.g., 6 to 9 months) for conditions such as endometriosis. These defined protocols outline how the medicine is used.

Recent Clinical Evidence

Norethisterone: Recent Clinical Evidence

Norethisterone was studied for use in premenopausal women with confirmed endometriosis, primarily through Randomized Controlled Trials (RCTs). These trials monitored outcomes related to pain intensity and changes in quality of life metrics. Studies documented measured changes in patient-reported pain levels observed during the study period. However, long-term outcomes regarding disease recurrence or durability of symptom patterns beyond two years are not fully established. Evidence is often derived from combination regimens, making the drug’s independent pattern challenging to isolate.

For Abnormal Uterine Bleeding (AUB) and Heavy Menstrual Bleeding (HMB), research examined outcomes related to systemic imbalance, focusing on measurements of menstrual blood loss (MBL) volume. Studies monitored the proportion of women who experienced an induction of withdrawal bleeding following a short course of treatment. Findings show patterns related to time intervals where a measured change in bleeding volume was observed. Comparative evidence is lacking for different dosing schedules used for managing abnormal bleeding, and there is limited information for long-term outcomes following treatment cessation.

For secondary amenorrhea (lack of a period), the progestin was observed in study populations to monitor physiological outcomes related to the occurrence of withdrawal bleeding. For contraception, effectiveness was monitored in large-scale Phase III Clinical Trials using the Pearl Index (failure rate) and cycle control measurements. These findings describe group patterns observed in controlled conditions, but reported effectiveness is highly dependent on user adherence in real-world settings.

Research Gaps and Areas of Uncertainty

Most symptom-focused research involves short-term or episodic follow-up (typically 6 to 12 months), meaning long-term effects are not fully characterized. Data for certain groups, such as adolescents or those with specific comorbid conditions, remain insufficient. Overall, evidence quality varies across studies, and research often relies on combining Norethisterone with other active ingredients, which makes isolating its independent pattern of change difficult.

Key Studies & References

  1. FDA Label: Norethindrone Acetate Tablets (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Norethisterone (FAQ)

Q: Is Norethisterone the same as the mini-pill?

Norethisterone (also known as Norethindrone) is the active hormone found in certain progestin-only oral contraceptive pills, which are commonly referred to as the mini-pill. These pills are a form of birth control that contain only a progestin hormone, without estrogen.

Q: Can Norethisterone be used for heavy bleeding?

Yes, regulatory and product information confirms that Norethisterone is officially indicated and used to treat gynecological conditions such as heavy menstrual bleeding (medically known as menorrhagia) and dysfunctional uterine bleeding. The medicine is intended to help manage and control abnormal bleeding patterns.

Q: Does taking Norethisterone delay ovulation or just a period?

The primary effect is to suppress the body's natural cycle, which may involve suppressing ovulation and/or preventing the monthly shedding of the uterine lining, depending on the dose prescribed. This mechanism influences the timing of menstruation while the medication is being taken.

Q: Is it normal to have spotting while taking Norethisterone?

Yes, spotting or irregular breakthrough bleeding is a common side effect documented in the official safety labeling for Norethisterone. This effect is generally noted in the safety profile as the body adjusts to the hormonal changes.

Q: Does Norethisterone affect blood pressure?

Elevated blood pressure (hypertension) has been reported in a small percentage of women using oral hormonal treatments, including those that contain Norethisterone. According to regulatory warnings, this effect is usually reversible once the medication is stopped.

Q: Is weight gain a common side effect of Norethisterone?

Changes in body weight, which may include weight gain or weight loss, are documented as a common or known side effect in the official safety profile for this medicine.

Q: Do antibiotics reduce the effectiveness of Norethisterone?

While not all antibiotics are known to interact, regulatory documents list certain types of anti-infectives, such as Rifampicin, as medications that can potentially increase the metabolism of Norethisterone. This may reduce the hormone levels in the body. If you are prescribed an antibiotic, your prescribing doctor or pharmacist can confirm the need for backup contraception.

Q: Is it safe to drink alcohol while on Norethisterone?

Official regulatory documents do not list a specific interaction between alcohol consumption and Norethisterone. Patients with concerns about alcohol should review them with their healthcare provider.

Q: What happens if you miss a tablet of Norethisterone?

Official guidance on missed doses is clearly defined for the contraceptive use of Norethisterone (the low-dose regimen). The instructions for managing a missed dose can vary significantly based on the dose and the condition being treated, so always refer to the patient leaflet provided with your specific medication.

Q: Is it common to feel bloated when taking Norethisterone?

Feeling bloated is sometimes noted as a potential side effect in the product information. The drug is also noted to require caution in individuals with medical conditions that are sensitive to fluid retention. This side effect is generally noted in the safety profile as the body adjusts to the hormonal changes.

Q: Is Norethisterone safe for someone with a history of migraines?

Official warnings require a complete medical history regarding migraines. Norethisterone is contraindicated (prohibited) for individuals who experience migraines with neurological symptoms (known as focal aura). Individuals with other types of migraines should ensure their doctor is aware of this condition.

Q: Does Norethisterone affect liver function?

The medicine is absolutely contraindicated for anyone with severe liver impairment or active liver disease. Furthermore, the drug has also been associated with rare risks of liver tumors and elevated liver enzymes.

Q: What foods or drinks should be avoided while taking Norethisterone?

Official regulatory documents specifically mention that Grapefruit juice may potentially increase the blood levels of Norethisterone. Additionally, some antacids may decrease the absorption of the medicine if they are taken too close together.

Q: Does Norethisterone need to be taken at the exact same time every day?

Yes, when Norethisterone is used for the purpose of contraception (low-dose regimen), the official instructions require that the tablets be taken at the same time every day. Consistent timing is necessary to maintain adequate progestin levels, which is important for the medication’s intended effect.

Q: Will taking Norethisterone interfere with the results of blood tests?

Official product information notes that taking Norethisterone can potentially interfere with the results of various laboratory tests. This includes tests for liver, thyroid, adrenal, and sex hormone levels, as the medicine can sometimes alter test measurements.

Q: Why is it important to inform your doctor about a history of depression before taking Norethisterone?

Because depression or depressed mood is listed as a possible side effect, patients with a pre-existing history of depression should ensure this is known as part of their overall risk assessment.

Q: Does sun exposure or tanning affect Norethisterone's side effects?

Official warnings advise individuals with a history of chloasma (brown patches on the skin) to minimize exposure to the sun and ultraviolet light while using this medication.

Q: Is Norethisterone often prescribed to teenagers?

Official labeling states that the medicine should not be started before menarche (the first period). Use is then guided by the labeled indications.

Q: Are there any foods that can enhance or decrease the absorption of Norethisterone?

Official regulatory data indicates that certain antacids may decrease the absorption of Norethisterone if taken within a two-hour window of the tablet. Conversely, grapefruit juice has been noted to potentially increase the blood levels of the medicine.

How should Norethisterone be stored and disposed of?

How to Store and Dispose of Norethisterone

Norethisterone tablets must be stored at controlled room temperature, typically 20 C to 25 C. Storage requires protection from both light and moisture, and the product should be kept in the original container, which must be tightly closed. Avoid storing the medicine in areas subject to excessive heat or humidity.

Crucially, the tablets must always be stored out of the sight and reach of children.

Disposal must strictly follow local regulations for pharmaceutical waste. Do not discard unused or expired Norethisterone in household trash, and never dispose of it by pouring or flushing it down a drain or into wastewater. Instead, return the product to a pharmacy or an authorized medicine take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Norethisterone found in:

A-Z Index: